Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-01-11
2011-01-11
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C514S170000
Reexamination Certificate
active
07867515
ABSTRACT:
The present invention is directed to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising progestin and methods of making and using the dosage forms to treat conditions in females in need thereof.
REFERENCES:
patent: 5770227 (1998-06-01), Dong et al.
patent: 6086916 (2000-07-01), Agnus et al.
patent: 6156742 (2000-12-01), Mackenzie
patent: 6316029 (2001-11-01), Jain et al.
patent: 6368625 (2002-04-01), Siebert et al.
patent: 6667050 (2003-12-01), Boissonneault et al.
patent: 2002/0034540 (2002-03-01), Price
patent: 2005/0013857 (2005-01-01), Fu et al.
patent: 2005/0032755 (2005-02-01), van Look et al.
patent: 2005/0196440 (2005-09-01), Masters et al.
patent: 2005/0288264 (2005-12-01), Van Look et al.
patent: 2006/0275360 (2006-12-01), Ahmed et al.
patent: 2009/0170823 (2009-07-01), DiLiberti
patent: 1634077 (2004-11-01), None
patent: 1161941 (2000-12-01), None
Task Force on Postovulatory Methods of Fertility Regulation, “Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation,”Lancet 352:428-433, Lancet Publishing Group (1998).
von Hertzen, H., et al., “Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial,”Lancet 360:1803-1810, Lancet Publishing Group (2002).
International Search Report for International Application No. PCT/US2007/25974, mailed on Sep. 8, 2008, United States Patent Office, Alexandria, Virginia.
Written Opinion for International Application No. PCT/US2007/25974, mailed on Sep. 8, 2008, United States Patent Office, Alexandria, Virginia.
English language abstract of CN 1634077 A (Document FP2).
Plan B® Product Packaging and Information Label, Duramed Pharmaceuticals, Inc., Montvale, New Jersey (Sep. 2006).
Ahmed Salah U.
Chowdhury Tahseen A.
Sethia Sundeep
Barham Bethany
Sterne Kessler Goldstein & Fox P.L.L.C.
TEVA Woman's Health, Inc.
Wax Robert A
LandOfFree
Orally disintegrating solid dosage forms comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orally disintegrating solid dosage forms comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally disintegrating solid dosage forms comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2705328